Mixed messages from Pfizer-BioNTech on vaccine reduction
Pfizer-BioNTech is sending mixed messages about COVID-19 vaccine shipments to Canada, telling Ottawa there will be a delay in deliveries, despite the drug company ramping up its manufacturing capacity in Europe. David Akin reports.
UP NEXT
UP NEXT
-
Protestors calling on federal government to sign emergency order to save Île-Perrot forest
Global News
-
N.B. premier and opposition at odds over AG access to Vestcor
Global News
-
Peterborough Public Health Declares Outbreak in Student Residence
Global News
-
Trudeau admits vaccine effort has lagged
cbc.ca
-
Laura Walker and Team Alberta eliminate Jennifer Jones and Team Manitoba at Scotties
cbc.ca
-
Tranquil flurries fill the driveways in Stittsville, ON
The Weather Network
-
'By protecting the most vulnerable...we protect everyone': Joe Cressy, chair of Toronto's Board of Health
cbc.ca
-
Michael Kovrig’s wife says she hopes Biden’s ‘powerful’ words will lead to action
Global News
-
Switzerland's Lara Gut-Behrami captures super-G overall title
cbc.ca
-
U.S. approves Johnson & Johnson’s singe-shot COVID-19 vaccine
Global News
-
Ontario pumps so-called “emergency brakes” placing two regions in lockdown
Global News
-
China's ambassador to Canada dismisses accusations of Uighur genocide
cbc.ca
-
Graphic Warning: Austria's Rosina Schneeberger crashes during Sunday's World Cup
cbc.ca
-
Graphic Warning: Norway's Kajsa Vickhoff Lie crashes during Sunday's World Cup super-G race
cbc.ca
-
A community rallies for one of its own
CityNews
-
This is how Canadians celebrate the roaring game
cbc.ca